(19)
(11) EP 1 545 586 A2

(12)

(88) Date of publication A3:
16.09.2004

(43) Date of publication:
29.06.2005 Bulletin 2005/26

(21) Application number: 03755796.4

(22) Date of filing: 09.09.2003
(51) International Patent Classification (IPC)7: A61K 38/18, A61K 38/16, A61K 38/22, C07K 1/10, C07K 14/505
(86) International application number:
PCT/US2003/028073
(87) International publication number:
WO 2004/022577 (18.03.2004 Gazette 2004/12)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 09.09.2002 US 409020 P

(71) Applicants:
  • Warren Pharmaceuticals, Inc.
    Ossining, NY 10562 (US)
  • The Kenneth S. Warren Institute, Inc.
    Ossining, NY 10562 (US)

(72) Inventors:
  • CERAMI, Anthony
    Croton-on-Hudson, NY 10520 (US)
  • SMART, John
    Palmetto, FL 34221 (US)
  • BRINES, Michael
    Woodbridge, CT 06525 (US)
  • CERAMI, Carla
    Sleepy Hollow, NY 10591 (US)

(74) Representative: Jones Day 
Rechtsanwälte, Attorneys-at-Law, PatentanwältePrinzregentenstrasse 11
80538 München
80538 München (DE)

   


(54) LONG ACTING ERYTHROPOIETINS THAT MAINTAIN TISSUE PROTECTIVE ACTIVITY OF ENDOGENOUS ERYTHROPOIETIN